Beam Therapeutics Inc. short interest in 2024
In 2024, Beam Therapeutics Inc.'s disclosed short interest ran from 16.11% of shares outstanding on 12 Jan 2024 to 11.87% on 31 Dec 2024, a change of -4.24 percentage points. The year's high was 17.72% on 15 May 2024 and its low 11.87% on 31 Dec 2024, averaging 14.98% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.27 days on 13 Sep 2024. Full history: Beam Therapeutics Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 16.11% (12 Jan 2024)
- End of year
- 11.87% (31 Dec 2024)
- Change
- -4.24 pp
- High
- 17.72% (15 May 2024)
- Low
- 11.87% (31 Dec 2024)
- Average
- 14.98%
- Highest days to cover
- 18.27 (13 Sep 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 16.11% | 13.13 | results (8-K) |
| 31 Jan 2024 | 16.43% | 9.73 | |
| 15 Feb 2024 | 16.48% | 9.09 | |
| 29 Feb 2024 | 16.08% | 6.33 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 17.57% | 10.48 | |
| 28 Mar 2024 | 16.50% | 15.54 | |
| 15 Apr 2024 | 16.16% | 9.16 | |
| 30 Apr 2024 | 17.03% | 7.93 | |
| 15 May 2024 | 17.72% | 11.82 | 10-Q filed, results (8-K) |
| 31 May 2024 | 16.80% | 15.91 | |
| 14 Jun 2024 | 15.73% | 9.52 | |
| 28 Jun 2024 | 14.33% | 6.44 | |
| 15 Jul 2024 | 14.65% | 13.18 | |
| 31 Jul 2024 | 14.10% | 7.02 | |
| 15 Aug 2024 | 13.56% | 12.08 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 13.45% | 16.29 | |
| 13 Sep 2024 | 13.30% | 18.27 | |
| 30 Sep 2024 | 13.78% | 13.05 | |
| 15 Oct 2024 | 13.54% | 15.24 | |
| 31 Oct 2024 | 14.87% | 10.91 | |
| 15 Nov 2024 | 14.45% | 8.27 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 12.90% | 10.79 | |
| 13 Dec 2024 | 12.15% | 9.06 | |
| 31 Dec 2024 | 11.87% | 8.58 |
See also: Beam Therapeutics Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.